MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Bleomycin hydrochloride

CAS No. : 67763-87-5

MCE 站：Bleomycin hydrochloride

产品活性：Bleomycin hydrochloride 是一种 DNA 损伤剂，抑制 DNA 合成。Bleomycin hydrochloride 是一种抗肿瘤抗生素 (antibiotic)。

研究领域：Cell Cycle/DNA Damage  |  Anti-infection

作用靶点：DNA/RNA Synthesis  |  Antibiotic

In Vitro: Bleomycin hydrochloride is chosen as the best-studied micronucleus inducers in human lymphocytes with different mechanisms of genotoxicity. The most frequent Bleomycin-induced DNA lesions are single and double strand breaks and single apuinic/apyrimidinic sites. At the same time Bleomycin is true radiomimetic compound, resembling almost completely the genetic effect of ionizing radiation.
The IC₅₀ value of Bleomycin hydrochloride for UT-SCC-19A cell line is 4.0±1.3 nM. UT-SCC-12A and UT-SCC-12B are both more resistant to Bleomycin; IC₅₀ values are 14.2±2.8 nM and 13.0±1.1 nM, respectively.
Bleomycin hydrochloride (50, 100?μM; for 24, 48?h) induce pulmonary fibrosis in RLE-6TN cell (50?μM) and A549 cell (100?μM).

In Vivo: Bleomycin hydrochloride treatment (3.5-4.0?mg/kg; intra-tracheal) on day 0, body weights decreases by day 4 then increases by Day 7 through the end of the study.
Bleomycin hydrochloride (3.5-4.0?mg/kg; intra-tracheal) produces a statistically significant increase in lung hydroxyproline levels, and also increases right caudal lung lobe mass.
Bleomycin hydrochloride (intratracheal instillation; 5.0?mg/kg/day) induces pulmonary fibrosis in eighty 8-week-old male BALB/c mice with weight about 20-30?g. Bleomycin induces the expression levels of α-SMA and collagen I.
Bleomycin hydrochloride (intratracheally; 2.5?mg/kg; 1.25?mg/ml, approximately 50??l per mouse) induces pulmonary fibrosis in male C57BL/6 mice (8?weeks old, average weight approximately 24.5?g).

相关产品：Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Cell Cycle/DNA Damage Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  Antibiotics Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Animal Disease Model Inducer Library  |  Rapamycin  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Chloroquine  |  Puromycin dihydrochloride  |  Cycloheximide  |  Dexamethasone  |  Staurosporine  |  Remdesivir  |  Oxaliplatin  |  Gemcitabine  |  G-418 disulfate  |  Doxycycline (hyclate)  |  Cyclosporin A  |  5-Azacytidine  |  Etoposide  |  Nigericin sodium salt  |  Actinomycin D  |  Brefeldin A  |  Resveratrol  |  Mitomycin C  |  Wortmannin  |  Hygromycin B  |  Bleomycin sulfate  |  Tunicamycin  |  Carboplatin  |  Tacrolimus  |  Ionomycin  |  Cytarabine

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。